2024

Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
Abeck F, Hansen I, Kött J, Schröder F, Garrahy E, Veneroso J, Rünger A, Torster L, Schneider S, von Büren J
J COSMET DERMATOL-US. 2024;23(9):2956-2963.

Successful treatment of non-uremic calciphylaxis with combination therapy with sodium thiosulfate, iloprost, and heparin
Abeck F, Hansen I, Rünger A, Booken N, Schneider S
INT J DERMATOL. 2024;63(7):962-963.

Effects of a skin type diversity seminar on undergraduate medical students' self-assessed competence in managing skin diseases in patients with skin of color
Abeck F, Heinen I, Sommer R, Blome C, Härter M, Augustin M, Schneider S, Hansen-Abeck I, Booken N
BMC MED EDUC. 2024;24(1):848.

Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanoma
Geidel G, Abeck F, Hansen I, Kött J, Heidrich I, Rünger A, Hildebrandt L, Gebhardt C
J EUR ACAD DERMATOL. 2024;38(6):e473-e475.

Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanoma
Geidel G, Parnian N, Meß C, Schlepper N, Rünger A, Heidrich I, Hansen I, Smit D, Menz A, Pantel K, Schneider S, Kött J, Gebhardt C
J EUR ACAD DERMATOL. 2024;38(10):2017-2023.

Posttransplantation course after allogeneic stem cell transplantation in a patient with advanced mycosis fungoides—Balancing relapse and rejection
Hansen-Abeck I, Blomen C, Abeck F, Torster L, Schneider S, Booken N
Journal of the European Academy of Dermatology and Venerology Clinical Practice. 2024.

Characterization of non-IgA vasculitis: Demographic, clinical, and treatment-related features in a retrospective analysis of 28 biopsy-confirmed cases from a German university hospital
Hansen-Abeck I, Rünger A, Piepke L, Kött J, Giordano-Rosenbaum A, Menz A, Abeck F, Schneider S
J DERMATOL. 2024 [Epub ahead of print].

Mogamulizumab-associated rash - Case series and review of the literature
Hansen I, Abeck F, Menz A, Schneider S, Booken N
J DTSCH DERMATOL GES. 2024;22(8):1079-1086.

Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom
Hansen I, Gebhardt C, Booken N, Schneider S
J DTSCH DERMATOL GES. 2024;22(4):587-590.

Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma
Hansen I, Gebhardt C, Booken N, Schneider S
J DTSCH DERMATOL GES. 2024;22(4):587-589.

Current impact of inpatient dermatological consultations at a university hospital in Germany
Hansen I, Köser C, Kött J, Schneider S, Abeck F
J DTSCH DERMATOL GES. 2024;22(5):710-712.

Successful treatment of refractory checkpoint inhibitor-induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
Hansen I, Kött J, Heidenreich S, Ayuk F, Doll P, Abeck F, Booken N, Gebhardt C, Schneider S
Journal of the European Academy of Dermatology and Venerology Clinical Practice. 2024;3(1):317-320.

Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma
Hansen I, Rünger A, Noebel C, Geidel G, Kött J, Menz A, Hildebrandt L, Schneider S, Gebhardt C
J EUR ACAD DERMATOL. 2024;38(9):e820-e822.

Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg
Kött J, Zell T, Zimmermann N, Rünger A, Smit D, Abeck F, Geidel G, Hansen-Abeck I, Heidrich I, Weichenthal M, Ugurel S, Leiter U, Berking C, Gutzmer R, Schadendorf D, Zimmer L, Livingstone E, Wasielewski I, Mohr P, Meier F, Haferkamp S, Drexler K, Herbst R, Kellner I, Utikal J, Wohlfeil S, Pföhler C, Adam L, Meiss F, Möbes M, Welzel J, Schilling B, Ziller F, Kaatz M, Kreuter A, Sindrilaru A, Dippel E, Sachse M, Weishaupt C, Hüning S, Heinzerling L, Loquai C, Bauer A, Schneider S, Gebhardt C
EUR J CANCER. 2024 [Epub ahead of print];214:115159.

C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma
Kött J, Zimmermann N, Zell T, Heidrich I, Geidel G, Rünger A, Smit D, Merkle M, Parnian N, Hansen I, Hoehne I, Abeck F, Torster L, Weichenthal M, Pantel K, Schneider S, Gebhardt C
J EUR ACAD DERMATOL. 2024;38(8):1575–1587.

Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy
Kött J, Zimmermann N, Zell T, Rünger A, Heidrich I, Geidel G, Smit D, Hansen I, Abeck F, Schadendorf D, Eggermont A, Puig S, Hauschild A, Gebhardt C
EUR J CANCER. 2024;202:.

2023

A Rejected Hypothesis: Phenomenon of High Treatment Adherence in Direct-to-Consumer Teledermatology Despite Lack of Direct Physician-Patient Interaction
Abeck F, Hansen I, Wiesenhütter I, Brookman-May S, Sharaf K, Kött J, Bertlich M, Schneider S, von Büren J
TELEMED E-HEALTH. 2023;29(7):1051-1056.

Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia
Abeck F, Hansen I, Wiesenhütter I, Schröder F, Kött J, Schneider S, von Büren J
CLIN COSMET INV DERM. 2023;16:937-945.

Direct-to-Consumer Teledermatology in Germany: A Retrospective Analysis of 1,999 Teleconsultations Suggests Positive Impact on Patient Care
Abeck F, Kött J, Bertlich M, Wiesenhütter I, Schröder F, Hansen I, Schneider S, von Büren J
TELEMED E-HEALTH. 2023;29(10):1484-1491.

The potential of telemedicine for dermatological care of pediatric patients in Germany
Hansen I, Abeck D, Kött J, Schneider S, Abeck F
J DTSCH DERMATOL GES. 2023;21(2):141-145.

Asymptomatic erythematous plaque on the lower leg
Hansen I, Abeck F, Heidrich I, Schneider S, Booken N
J DTSCH DERMATOL GES. 2023;21(7):813-815.

Asymptomatische erythematöse Plaque am Unterschenkel
Hansen I, Abeck F, Heidrich I, Schneider S, Booken N
J DTSCH DERMATOL GES. 2023;21(7):813-815.

Therapie des nekrobiotischen Xanthogranuloms - Fallserie und aktuelle Literatur:
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1319.

Therapy of necrobiotic xanthogranuloma - case series and review of the literature
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1318.

Letaler Verlauf einer Kryoglobulinämie Typ I
Hansen I, Ghandili S, Abeck F, Kött J, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(Suppl 2):15-18.

Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab
Hansen I, Heidrich I, Abeck F, Kött J, Booken N, Gebhardt C, Schneider S
J EUR ACAD DERMATOL. 2023;37(5):e621-e623.

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
Ninosu N, Melchers S, Kappenstein M, Booken N, Hansen I, Blanchard M, Guenova E, Assaf C, Goerdt S, Nicolay J
CANCERS. 2023;16(1):.

Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
von Büren J, Hansen I, Kött J, Schröder F, Veneroso J, Schneider S, Abeck F
DIGIT HEALTH. 2023;9:20552076231205740.

2022

Telemedical care of men with androgenetic alopecia demonstrates improved access to care and patient benefit
Abeck F, Kött J, Wiesenhütter I, Hiebenthal T, Hansen I, Schneider S, von Büren J
J EUR ACAD DERMATOL. 2022;36(12):e1018-e1020.

Epidemiologie von Hautkrankheiten in Deutschland: systematische Literaturanalyse des aktuellen Forschungsstands - Teil 1: Tumorerkrankungen der Haut
Hansen I, Augustin M, Schäfer I, Mohr N
J DTSCH DERMATOL GES. 2022;20(3):257-271.

Epidemiologie von Hautkrankheiten in Deutschland: systematische Literaturanalyse des aktuellen Forschungsstands - Teil 2: nichtinfektiöse Hauterkrankungen
Hansen I, Augustin M, Schäfer I, Mohr N
J DTSCH DERMATOL GES. 2022;20(4):445-457.

Epidemiologie von Hautkrankheiten in Deutschland: Systematische Literaturanalyse des aktuellen Forschungsstands - Teil 3: infektiöse Hauterkrankungen
Hansen I, Augustin M, Schäfer I, Mohr N
J DTSCH DERMATOL GES. 2022;20(5):589-596.

Epidemiology of skin diseases in Germany: systematic review of the current state of research - part 1: cutaneous tumor diseases
Hansen I, Augustin M, Schäfer I, Mohr N
J DTSCH DERMATOL GES. 2022;20(3):257-270.

Epidemiology of skin diseases in Germany: systematic review of the current state of research - part 2: non-infectious skin diseases
Hansen I, Augustin M, Schäfer I, Mohr N
J DTSCH DERMATOL GES. 2022;20(4):445-455.

Epidemiology of skin diseases in Germany: systematic review of the current state of research - part 3: infectious skin diseases
Hansen I, Augustin M, Schäfer I, Mohr N
J DTSCH DERMATOL GES. 2022;20(5):589-595.

Acute Generalized Exanthematous Pustulosis
Hansen I, Booken N, Schneider S
DTSCH ARZTEBL INT. 2022;119(50):878.

Ungewöhnliche Lokalisation einer klassischen Dermatose
Hansen I, Kött J, Booken N, Schneider S
DERMATOLOGIE. 2022;73(11):901-903.

2021

Palmar wrinkling after water exposure in a child
Hansen I, Abeck D
J DTSCH DERMATOL GES. 2021;19(1):144-146.

Schwellung und Faltenbildung der Hände nach Wasserkontakt bei einem Kind
Hansen I, Abeck D
J DTSCH DERMATOL GES. 2021;19(1):144-146.

2020

Pränataler Koffeinkonsum und Geburtsgewicht
Hansen I, Windler E, Zyriax B
Frauenarzt. 2020;61(3):190-195.

Letzte Aktualisierung aus dem FIS: 20.12.2024 - 23:33 Uhr